Global Tumor Ablation Devices Market, by Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, High-Intensity Focused Ultrasound, Laser Interstitial Thermal Ablation and Others), by Application (Blood Cancer, Breast Cancer, Liver Cancer, Prostate Cancer, Lung Cancer, Kidney Cancer and Others), and By End User (Hospitals and Ambulatory Surgical Centers) and by Geography - Trends and Forecast to 2025

  • Published On : Feb 2018 |
  • Pages : 152 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Global Tumor Ablation Devices Market - Insights

With the robust development of imaging devices and modalities during past two decades, image guided techniques like tumor ablation has become a powerful tool for definitive treatment of certain benign and malignant tumors of the lungs, liver, kidneys, bone, and soft tissues and for pain palliation. Tumor ablation is one of the minimally invasive procedure used to destroy cancer cells in the chest, lung and liver and other areas of patients’ body. The change in lifestyle and unhealthy eating habits, along with increasing consumption of tobacco and alcohol is the leading cause for growth in number of cancer cases. As per stats released by National Cancer Institute (NCI), around 1,685,210 new cases of cancer were diagnosed in the U.S. in 2016.

The global tumor ablation devices market is valued at US$ 464.18 million in 2017 and is expected to witness a CAGR of 10.2% over the forecast period (2017 – 2025).

Figure 1. Global Tumor Ablation Devices Market Share, by Region, 2017 (%)

Tumor Ablation Devices

Source: Coherent Market Insights Analysis (2017)

New product launches by manufacturers is a prominent factor fueling market growth

Increasing prevalence of various cancer globally rising the demand of treatment through ablation procedure due to its lesser/minimal side effect rates over other procedures intended to boost the tumor ablation devices market. According to the World Health Organization (WHO), cancer is one of the leading causes of morbidity and mortality across the world, with approximately 14 million new cases reported worldwide in 2012.

Tumor Ablation devices market is focused towards the benign tumors and early forms of malignant tumors treatment that can be removed with the help of minimally invasive surgical methods. According to the World Health Organization (WHO) data 2012, 30-50% deaths caused due to cancer can be prevented by adequate treatment in early stages and can drastically reduce risk factors. Companies in tumor ablation devices market are focusing towards enhancing its strength through new product launches within shorter product approval time than required, merger & acquisition to enhance their product portfolio and increase the visibility of the market over the forecast period.

For instance, in 2016, Ethicon (A Johnson & Johnson (J&J) company) acquired NeuWave Medical Inc., a medical device company, which manufactures and markets minimally invasive soft tissue microwave ablation systems. These acquisition will help J&J to expand its product portfolio in the ablation devices market. On the contrary, the high costs associated with the devices mainly cryoablation devices are usually unaffordable to middle class and low income population. This high cost incurred with these devices acts as a hindrance for the global market growth. However, these devices has few advantages over open surgeries. Firstly, the cost incurred by these surgical procedures are relatively less than that open surgical procedures. Secondly, these devices are of great convenience when it comes to pain reduction, accuracy and efficiency.

Emerging economies to fuel the market growth

On the basis of regional segmentation, the global tumor ablation devices market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to account for the largest share followed by Europe and Asia Pacific. Tumor ablation devices market in North America is driven by factors, such as trend of replacing older technologies and introducing the new technologies, and increase in private and public funding to develop and commercialize the novel tumor ablation products. For instance, in 2016, EDAP TMS has made high-intensity focused ultrasound (HIFU) systems, robotic device that allows for the safe ablation of prostate tissue, available in the prestigious institutions such as USC in Los Angeles, University of Miami, Duke University, the Cleveland Clinic, thus building awareness, allowing global adoption of the technology with rapid U.S. market penetration.

The market is also expected to gain significant traction in emerging economies of Asia Pacific, due to projected spurt in number of cancer cases detected in the region and the implementation of government initiatives to build healthcare infrastructure. For instance, the government of China in 2016 had spent around US$ 371 billion on healthcare reforms and US$ 100 billion in providing insurance to the citizens, improving the infrastructure of public hospitals and community healthcare facilities. The growing awareness of diagnostic procedures and treatment options for certain cancers has created tremendous opportunities for the growth of vendors in the market.

The key players operating in the global market of tumor ablation devices include Boston Scientific Corporation, Medtronic Plc, Intuitive Surgical, Inc., Johnson & Johnson, Smith & Nephew Plc., Angiodynamics, HealthTronics, Inc, SonaCare Medical, LLC., Galil Medical Inc., EDAP TMS S.A., Abbott Laboratories, NuVasive, Inc, Alpinion Medical Systems Co., Ltd.

Tumor ablation is a minimally invasive procedure to remove the tumor cells or tissue from the body. Tumor ablation devices are consists of a catheter, which is introduced into the tumor under imaging guidance. Advancements in cryosurgical technology and intraoperative monitoring devices have gained the adoption of tumor ablation devices by the healthcare professionals. As this technology have led to the implementation of high accuracy and precision in treating chronic diseases such as a liver tumor. The use of Microwave Ablation magnetic image-guiding systems has provided an effective adjunct in laparoscopic ablation and helps in providing better support to surgeons and increases clinical patient outcome.

Market Dynamics

Rising prevalence of tumor cases is the major factor that contributes in the growth of the tumor ablation devices market. According the Central Brain Tumor Registry of the US (CBTRUS), 2015, there are over 138,000 people in the US living with primary brain and central nervous system malignant tumors. Various key players are involved in sustainable development of minimally invasive ablation devices for various types such as catheter ablation, cryoablators, etc. Moreover, key players are also indulged in offering various lucrative features to the potential buyers of the ablation devices such as hospitals and clinics that would in turn help them to grow their sales and establish a global market presence. For instance, Medtronic launched OsteoCool RF Ablation System to treat spine metastases, in January 2016. The system destroys cancer cells by using high frequency energy, and also provides procedural flexibility and tailored treatment for spine metastases. However, cost of the tumor treatment is relatively expensive which may restraint the growth of the market.     

Key features of the study:

  • This report provides in-depth analysis of tumor ablation devices and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, regulatory scenario, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global tumor ablation devices market based on the following parameters – company overview, financial performance, geographical presence, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Boston Scientific Corporation, Medtronic Plc, Intuitive Surgical, Inc., Johnson & Johnson, Inc., Smith & Nephew Plc., Angiodynamics, HealthTronics, Inc, SonaCare Medical, LLC., Galil Medical Inc., EDAP TMS S.A., Abbott Laboratories, NuVasive, Inc, and Alpinion Medical Systems Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, product improvement, market expansion, and marketing tactics
  • The global tumor ablation devices market report caters to various stakeholders in this industry including investors, researchers, tumor ablation devices manufacturers, new entrants, and financial analysts.
  • Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the tumor ablation devices market.

Detailed Segmentation:

  • Global Tumor Ablation Devices Market, By Technology:
    • Radiofrequency Ablation
    • Microwave Ablation
    • Cryoablation
    • High-Intensity Focused Ultrasound
    • Laser Interstitial Thermal Ablation
    • Others
  • Global Tumor Ablation Devices Market, By Application:
    • Breast Cancer
    • Liver Cancer
    • Prostate Cancer
    • Lung Cancer
    • Kidney Cancer
    • Others
  • Global Tumor Ablation Devices Market, By End User:
    • Hospitals
    • Ambulatory Surgical Centers
  • Global Tumor Ablation Devices Market, By Geography:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Technology:
        • Radiofrequency Ablation
        • Microwave Ablation
        • Cryoablation
        • High-Intensity Focused Ultrasound
        • Laser Interstitial Thermal Ablation
        • Others
      • By Application:
        • Breast Cancer
        • Liver Cancer
        • Prostate Cancer
        • Lung Cancer
        • Kidney Cancer
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Technology:
        • Radiofrequency Ablation
        • Microwave Ablation
        • Cryoablation
        • High-Intensity Focused Ultrasound
        • Laser Interstitial Thermal Ablation
        • Others
      • By Application:
        • Breast Cancer
        • Liver Cancer
        • Prostate Cancer
        • Lung Cancer
        • Kidney Cancer
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
    • Asia Pacific
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
      • By Technology:
        • Radiofrequency Ablation
        • Microwave Ablation
        • Cryoablation
        • High-Intensity Focused Ultrasound
        • Laser Interstitial Thermal Ablation
        • Others
      • By Application:
        • Breast Cancer
        • Liver Cancer
        • Prostate Cancer
        • Lung Cancer
        • Kidney Cancer
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Rest of Latin America
      • By Technology:
        • Radiofrequency Ablation
        • Microwave Ablation
        • Cryoablation
        • High-Intensity Focused Ultrasound
        • Laser Interstitial Thermal Ablation
        • Others
      • By Application:
        • Breast Cancer
        • Liver Cancer
        • Prostate Cancer
        • Lung Cancer
        • Kidney Cancer
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers  
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Technology:
        • Radiofrequency Ablation
        • Microwave Ablation
        • Cryoablation
        • High-Intensity Focused Ultrasound
        • Laser Interstitial Thermal Ablation
        • Others
      • By Application:
        • Breast Cancer
        • Liver Cancer
        • Prostate Cancer
        • Lung Cancer
        • Kidney Cancer
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
    • Africa
      • By Country:
        • North Africa
        • Central Africa
        • South Africa
      • By Technology:
        • Radiofrequency Ablation
        • Microwave Ablation
        • Cryoablation
        • High-Intensity Focused Ultrasound
        • Laser Interstitial Thermal Ablation
        • Others
      • By Application:
        • Breast Cancer
        • Liver Cancer
        • Prostate Cancer
        • Lung Cancer
        • Kidney Cancer
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers  
  • Company Profiles
    • Boston Scientific Corporation*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
      • Future Plans
    • Medtronic Plc
    • Intuitive Surgical, Inc
    • Johnson & Johnson, Inc
    • Smith & Nephew Plc
    • Angiodynamics
    • HealthTronics, Inc
    • SonaCare Medical, LLC
    • Galil Medical Inc.
    • EDAP TMS S.A
    • Abbott Laboratories
    • NuVasive, Inc
    • Alpinion Medical Systems Co., Ltd.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Technology
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Technological Advancements
    • Industry Trends
    • Reimbursement Scenario
    • PEST Analysis
    • PORTER’S Five Forces
  4. Global Tumor Ablation Devices Market, By Technology, 2017–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Radiofrequency Ablation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
    • Microwave Ablation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
    • Cryoablation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
    • High-Intensity Focused Ultrasound
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
    • Laser Interstitial Thermal Ablation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
  5. Global Tumor Ablation Devices Market, By Application, 2017–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Blood Cancer
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Breast Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
    • Liver Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
    • Prostate Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
    • Lung Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
    • Kidney Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
  6. Global Tumor Ablation Devices Market, By End User, 2017–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
    • Ambulatory Surgical centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Million)
  7. Global Tumor Ablation Devices Market, By Regions, 2017–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2017 and 2025 (%)
      • Y-o-Y Growth Analysis, By Region, 2017–2025
      • Regional Trends
    • North America
      • Market Size and Forecast, By Technology, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2017–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017–2025, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Technology, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2017–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017–2025, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Technology, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2017–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017–2025, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Technology, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2017–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017–2025, (US$ Million)
        • Brazil
        • Mexico
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Technology, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2017–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017–2025, (US$ Million)
        • Northern Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Technology, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2017–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2017–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017–2025, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
    • Company Profiles
      • Boston Scientific Corporation
        • Company Overview
        • Product Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Medtronic Plc
        • Company Overview
        • Product Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Intuitive Surgical, Inc
        • Company Overview
        • Product Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Johnson & Johnson, Inc
        • Company Overview
        • Product Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Smith & Nephew Plc
        • Company Overview
        • Product Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Angiodynamics
        • Company Overview
        • Product Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • HealthTronics, Inc
        • Company Overview
        • Product Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • SonaCare Medical, LLC
        • Company Overview
        • Product Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Galil Medical Inc.
        • Company Overview
        • Product Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • EDAP TMS S.A
        • Company Overview
        • Product Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Abbott Laboratories
        • Company Overview
        • Product Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • NuVasive, Inc
        • Company Overview
        • Product Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Alpinion Medical Systems Co., Ltd.
        • Company Overview
        • Product Technology Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
  9. Section
    • Analyst Views
    • Research Methodology
    • About Us and Sales Contact

*Browse 24 market data tables and 30 figures on "Tumor Ablation Devices Market - Global forecast to 2025”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.